Page 7 of 9
Dalton Transactions
Please do not adjust margins
Journal Name
ARTICLE
1
with a Z/E ratio of 97:3. H NMR (400 MHz, CDCl3) δ 8.25–8.07 (m,
1H), 6.99–6.87 (m, 1H), 5.88–5.75 (m, 1H), 5.73 – 5.53 (m, 1H), 4.25 ester (27), complex 11 (4.9 mg, 5.0 mol%) waDs OusI:e1d0..1T0h3e9/pCr9oDdTu0c1t0w16aEs
(d, J = 6.7 Hz, 1H), 4.08 (t, J = 6.4 Hz, 1H), 2.63 (q, J = 6.7 Hz, 1H), 1.60 a pale yellow oil (14.6 mg, yield 46%) with a Z/E ratio of 97:3. 1H NMR
(s, 1H) ppm. 13C NMR (100 MHz, CDCl3) δ 163.7, 131.7, 127.5, 125.9, (400 MHz, CDCl3) δ 8.00–7.93 (m, 1H), 6.90 (s, 1H), 5.66 (d, J = 3.1 Hz,
114.4, 67.9, 58.5, 27.4 ppm.
1H), 5.58–5.48 (m, 1H), 4.20 (t, J = 4.9 Hz, 1H), 4.0 –3.96 (m, 1H), 3.87
(d, J = 1.9 Hz, 1H), 2.20–2.10 (m, 1H), 1.83 (d, J = 6.2 Hz, 1H), 1.64 (d,
J = 9.3 Hz, 1H), 1.60–1.49 (m, 1H) ppm. 13C{1H} NMR (100 MHz, CDCl3)
δ 166.9, 162.8, 132.3, 131.6, 129.0, 122.4, 114.0, 67.9, 58.5, 51.9,
28.6, 27.1, 26.0 ppm. ESI-MS[M+Na]+calcd for C15H20NO4: 264.3210;
found: 287.1292. Analytical Data. Found (calcd) for: C15H20NO4 C,
68.16 (68.12); H, 7.63 (6.68).
For (Z)-7-(4-nitrophenoxy)hept-2-en-1-ol (21), complex 11 (4.9 mg,
5.0 mol%) was used. The product was a pale yellow oil (15.4 mg, yield
51%) with a Z/E ratio of 98:2. 1H NMR (400 MHz, CDCl3) δ 8.21–8.12
(m, 2H), 6.97–6.88 (m, 2H), 5.67–5.59 (m, 1H), 5.58–5.48 (m, 1H),
4.19 (d, J = 6.4 Hz, 2H), 4.04 (t, J = 6.4 Hz, 2H), 2.16 (q, J = 7.4 Hz, 2H),
1.82 (dd, J = 8.5, 6.9 Hz, 2H), 1.55 (dq, J = 15.0, 7.6 Hz, 3H) ppm.
13C{1H} NMR (100 MHz, CDCl3) δ 164.1, 141.3, 132.2, 129.1, 125.9,
For (Z)-12-hydroxydodec-10-en-1-yl benzoate (28)[14], complex 11
114.4, 68.6, 58.5, 28.5, 27.0, 25.9 ppm. ESI-MS [M+Na]+ calcd for (4.9 mg, 5.0 mol%) was used. The product was a pale yellow oil (21.9
C13H17NO4: 251.2820, found: 274.1042. Analytical Data. Found mg, yield 60%) with a Z/E ratio of 95:5. 1H NMR (400 MHz, CDCl3) δ
(calcd) for: C13H17NO4 C, 62.14 (62.27); H, 6.82 (6.88); N, 5.57(5.50).
8.04 (d, J = 7.8 Hz, 1H), 7.54 (t, J = 7.3 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H),
5.65–5.55 (m, 1H), 5.55–5.43 (m, 1H), 4.30 (t, J = 6.6 Hz, 1H), 4.18 (t,
J = 5.1 Hz, 1H), 2.05 (dd, J = 13.7, 6.8 Hz, 1H), 1.80–1.71 (m, 1H), 1.53
(s, 1H), 1.48–1.39 (m, 1H), 1.34 (s, 2H), 1.28 (s, 3H) ppm. 13C{1H} NMR
(100 MHz, CDCl3) δ 133.2, 132.8, 130.5, 129.5, 128.3, 65.1, 58.6, 29.6,
29.5 – 29.2, 29.2, 28.7, 27.4, 26.0 ppm.
For (Z)-4-hydroxybut-2-en-1-yl benzoate (22)[14], complex 11 (4.9
mg, 5.0 mol%) was used. The product was a pale yellow oil (7.6 mg,
yield 33%) with a Z/E ratio of 97:3. 1H NMR (400 MHz, CDCl3) δ 8.04
(d, J = 7.7 Hz, 1H), 7.56 (t, J = 7.4 Hz, 1H), 7.44 (t, J = 7.7 Hz, 1H), 5.92
(dt, J = 13.0, 7.7 Hz, 1H), 5.82–5.60 (m, 1H), 4.93 (d, J = 7.0 Hz, 1H),
4.34 (d, J = 6.5 Hz, 1H), 2.13 (s, 1H) ppm. 13C{1H} NMR (100 MHz,
For
(Z)-2-((5-hydroxypent-3-en-1-yl)oxy)benzaldehyde(29),
CDCl3) δ 166.7, 133.6, 133.1, 130.0, 129.6, 128.4, 125.6, 60.6, 58.5 complex 11 (4.9 mg, 5.0 mol%) was used. The product was a pale
ppm.
yellow oil (7.7 mg, yield 31%) with a Z/E ratio of 96:4. 1H NMR (400
MHz, CDCl3) δ 10.44 (s, 1H), 7.82 (dd, J = 7.7, 1.7 Hz, 1H), 7.57 – 7.49
(m, 1H), 7.03 (t, J = 7.5 Hz, 1H), 6.97 (d, J = 8.4 Hz, 1H), 5.80 (dt, J =
13.2, 6.7 Hz, 1H), 5.65 (dt, J = 10.9, 7.5 Hz, 1H), 4.26 (d, J = 6.6 Hz,
2H), 4.11 (t, J = 6.4 Hz, 2H), 2.66 (q, J = 6.7 Hz, 2H), 1.66 (s, 1H) ppm.
13C{1H} NMR (100 MHz, CDCl3) δ 189.9, 161.0, 135.9, 131.5, 129.0,
127.7, 120.8, 112.6, 67.7, 58.5, 27.5 ppm. ESI-MS [M+Na]+ calcd for
C12H14O3: 206.2410, found: 229.0835. Analytical Data. Found (calcd)
for: C12H14O3 C, 69.89 (69.96); H, 6.84 (6.87).
For (Z)-7-hydroxyhept-5-en-1-yl benzoate (23)[14], complex 11 (4.9
mg, 5.0 mol%) was used. The product was a pale yellow oil (15.9 mg,
yield 57%) with a Z/E ratio of 96:4. 1H NMR (400 MHz, CDCl3) δ 8.04
(d, J = 7.7 Hz, 1H), 7.56 (t, J = 7.4 Hz, 1H), 7.44 (t, J = 7.7 Hz, 1H), 5.68–
5.60 (m, 1H), 5.59 –5.50 (m, 1H), 4.33 (t, J = 6.6 Hz, 1H), 4.21 (d, J =
6.6 Hz, 1H), 2.16 (q, J = 7.3 Hz, 1H), 1.81–1.75 (m, 1H), 1.67 (s, 1H),
1.54 (dt, J = 15.0, 7.5 Hz, 1H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ
166.7, 132.9, 132.3, 130.3, 129.5, 129.0, 128.4, 64.7, 58.5, 28.2, 26.9,
25.9 ppm.
For (Z)-1-(3-hydroxy-4-(4-hydroxybut-2-en-1-yl)phenyl)e-than-1-
one (30)[14], complex 11 (4.9 mg, 5.0 mol%) was used. The product
For (Z)-2-(5-hydroxypent-3-en-1-yl)isoindoline-1,3-dione (24),
complex 11 (4.9 mg, 5.0 mol%) was used. The product was a white
solid (12.2 mg, yield 44%) with a Z/E ratio of 97:3. 1H NMR (400 MHz,
CDCl3) δ 7.84–7.76 (m, 2H), 7.72–7.64 (m, 2H), 5.73–5.62 (m, 1H),
5.56–5.45 (m, 1H), 4.11 (d, J = 6.2 Hz, 2H), 3.72 (t, J = 7.1 Hz, 2H), 2.47
(q, J = 7.3 Hz, 2H), 1.95 (s, 1H). ppm; 13C{1H} NMR (100 MHz, CDCl3) δ
168.4, 134.0, 132.0, 131.7, 127.90, 123.2, 58.3, 37.5, 26.5 ppm. ESI-
MS[M+Na]+ calcd for C13H13NO3: 231.2510; found: 254.0744.
Analytical Data. Found (calcd) for: C13H13NO3 C, 67.52 (67.46); H, 5.67
(5.75); N, 6.06 (6.00).
1
was a white solid (10.6 mg, yield 43%) with a Z/E ratio of 93:7. H
NMR (400 MHz, CDCl3) δ 7.79 (d, J = 2.0 Hz, 1H), 7.74 (dd, J = 8.4, 2.1
Hz, 1H), 6.84 (d, J = 8.4 Hz, 1H), 5.77 (dd, J = 11.6, 5.5 Hz, 1H), 5.67
(dd, J = 18.6, 8.0 Hz, 1H), 4.36 (d, J = 6.5 Hz, 1H), 3.52 (d, J = 7.9 Hz,
1H), 2.54 (d, J = 6.8 Hz, 1H), 1.36–1.19 (m, 1H) ppm. 13C{1H} NMR (100
MHz, CDCl3) δ 197.7, 159.9, 131.8, 131.2, 129.7, 129.4, 127.6, 125.9,
115.8, 58.4, 29.7, 26.3 ppm.
For
(Z)-3-(4-(trifluoromethyl)phenyl)prop-2-en-1-ol(31)[14]
,
complex 11 (4.9 mg, 5.0 mol%) was used. The product was a pale
yellow oil (7.0 mg, yield 29%) with a Z/E ratio of 91:9. 1H NMR (400
MHz, CDCl3) δ 7.60 (d, J = 8.1 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 6.60 (d,
J = 11.8 Hz, 1H), 6.05–5.94 (m, 1H), 4.42 (d, J = 6.4 Hz, 2H), 1.66 (s,
1H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 140.1, 133.2, 129.8, 129.0,
125.2, 59.5 ppm.
For (Z)-2-(7-hydroxyhept-5-en-1-yl)isoindoline-1,3-dione (25)[14]
,
complex 11 (4.9 mg, 5.0 mol%) was used. The product was a pale
yellow oil (16.5 mg, yield 53%) with a Z/E ratio of 97:3. 1H NMR (400
MHz, CDCl3) δ 7.84 (dd, J = 5.4, 3.1 Hz, 2H), 7.72 (dd, J = 5.4, 3.0 Hz,
2H), 5.69–5.60 (m, 1H), 5.54–5.44 (m, 1H), 4.21 (d, J = 6.8 Hz, 2H),
3.73 –3.64 (m, 2H), 2.16 (q, J = 7.2 Hz, 2H), 1.76 (s, 1H), 1.72 –1.65
For (Z)-3-phenylprop-2-en-1-ol (32)[14], complex 11 (4.9 mg, 5.0
(m, 2H), 1.49–1.40 (m, 2H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ mol%) was used. The product was a pale yellow oil (3.7 mg, yield
168.5, 133.9, 132.1, 129.2, 123.2, 58.5, 37.6, 27.7, 26.5, 26.4 ppm.
23%) with a Z/E ratio of 92:8. 1H NMR (400 MHz, CDCl3) δ 7.35 (t, J =
7.6 Hz, 2H), 7.29–7.26 (m, 1H), 7.21 (d, J = 7.6 Hz, 2H), 6.58 (d, J =
11.7 Hz, 1H), 5.88 (dt, J = 12.5, 6.4 Hz, 1H), 4.45 (d, J = 6.4 Hz, 2H),
1.55 (s, 1H) ppm. 13C{1H} NMR (100 MHz, CDCl3) δ 136.5, 131.1, 128.8,
128.3, 127.3, 59.7 ppm.
For benzoic acid, 4-[[(3Z)-5-hydroxy-3-penten-1-yl]oxy]-, methyl
ester (26), complex 11 (4.9 mg, 5.0 mol%) was used. The product was
a pale yellow oil (11.3 mg, yield 40%) with a Z/E ratio of 97:3. 1H NMR
(400 MHz, CDCl3) δ 8.02 – 7.89 (m, 2H), 6.94 – 6.81 (m, 2H), 5.84–
5.70 (m, 1H), 5.62 (dtt, J = 10.2, 7.5, 1.2 Hz, 1H), 4.22 (d, J = 6.6 Hz,
For (Z)-2,2'-(dec-5-ene-1,10-diyl)bis(isoindoline-1,3-dione) (33),
2H), 4.01 (t, J = 6.5 Hz, 2H), 3.86 (s, 3H), 2.66–2.50 (m, 2H), 1.99 (s, complex 11 (9.8 mg, 10.0 mol%) was used. The product was a pale
1H) ppm; 13C{1H} NMR (100 MHz, CDCl3) δ 166.8, 162.4, 131.6, 131.5, yellow solid (9.8 mg, yield 38%) with a Z/E ratio of 70:30. H NMR
1
127.9, 122.8, 114.0, 67.2, 58.4, 51.9, 27.5 ppm. ESI-MS[M+Na]+calcd (400 MHz, CDCl3) δ 7.82 (dd, J = 5.4, 3.1 Hz, 4H), 7.69 (dd, J = 5.4, 3.0
for C13H16O4: 236.2670; found: 259.0933. Analytical Data. Found Hz, 4H), 5.32 (t, J = 4.6 Hz, 2H), 3.67 (dd, J = 8.5, 6.0 Hz, 4H), 2.06 (dd,
(calcd) for: C13H16O4 C, 66.09 (66.02); H, 6.83 (6.72).
J = 12.6, 7.1 Hz, 4H), 1.67 (dd, J = 15.1, 7.5 Hz, 4H), 1.38 (dt, J = 15.0,
This journal is © The Royal Society of Chemistry 20xx
J. Name., 2013, 00, 1-3 | 7
Please do not adjust margins